Close Menu

NEW YORK (360Dx) – Laboratory Corporation of America today reported 8 percent year-over-year revenue growth companywide for the third quarter while the company's diagnostics revenues were flat.

Total revenues for the quarter was $2.83 billion, up from $2.62 billion in the third quarter of 2017, and missed the consensus Wall Street estimate of $2.84 billion.

Growth was driven largely by acquisitions, which accounted for 6.5 percent of growth, and strong performance in the company's Covance drug development business. Organically, revenues were up almost 3 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.